Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2019192281
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019192281
Title / Product Name
ANGIOPOIETIN-LIKE-3 (ANGPTL3)-IRNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019192281
EP Publication Number
3656860
E-Number
1485181
Language
EN
PCT Number
Publication Date
27.05.2020 A
20.04.2022 B1
Registration Date
20.04.2022
AT Publication Date
15.05.2022
Application Date
20.06.2012
Registration Number
-
Priorities
21.06.2011
US
201161499620 P
25.04.2012
US
201261638288 P
IPC
C12N 15/113 20100101AFI20211029BHEP
Maximum Duration of Protection
20.06.2032
Owner
Alnylam Pharmaceuticals, Inc.
300 Third Street, 3rd Floor
Cambridge, MA 02142
US
Representative
No representatives present
Inventor
BETTENCOURT, Brian
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
QUERBES, William
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
FITZGERALD, Kevin
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
FRANK-KAMENETSKY, Maria
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
MILSTEIN, Stuart
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
SHULGA-MORSKAYA, Svetlana
c/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor
Cambridge, MA 02142
US
see.ip - Details for ANGIOPOIETIN-LIKE-3 (ANGPTL3)-IRNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON